デフォルト表紙
市場調査レポート
商品コード
1593503

アテレクトミー装置の世界市場規模、シェア、成長分析:製品別、用途別、エンドユーザー別、地域別 - 産業予測(2024年~2031年)

Atherectomy Devices Market Size, Share, Growth Analysis, By Product (Directional Atherectomy Devices, Orbital Atherectomy Devices), By Application (Peripheral Vascular, Cardiovascular,), By End User, By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 186 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
アテレクトミー装置の世界市場規模、シェア、成長分析:製品別、用途別、エンドユーザー別、地域別 - 産業予測(2024年~2031年)
出版日: 2024年11月09日
発行: SkyQuest
ページ情報: 英文 186 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のアテレクトミー装置の市場規模は、2022年に約8億9,030万米ドルと評価され、2023年の9億6,241万米ドルから上昇し、予測期間(2024年~2031年)のCAGRは8.1%で、2031年には17億9,460万米ドルに達すると予測されます。

アテレクトミー装置の世界市場は、高齢者人口の増加、生活習慣の乱れ、不健康な食習慣によってますます蔓延している心血管疾患の発生率の上昇が主な要因となって、大きく成長する見通しです。このような健康上の懸念の高まりは、より多くの患者が効果的な治療法を求めるようになり、アテレクトミー装置の需要を高めると予想されます。さらに、低侵襲手術の動向は牽引力を増しており、医療専門家と患者が同様に心血管系の介入に低侵襲な選択肢を好む中、アテレクトミー装置のプロバイダーに新たな道を提示しています。さらに、医療研究開発への継続的な投資により、アテレクトミー装置の技術進歩が促進され、この分野にさらなるビジネスチャンスが生まれると予想されます。しかし、アテレクトミー手術や装置に関連する高額な費用、手術中の合併症の潜在的リスク、代替治療オプションの利用可能性などの課題に直面しており、長期的には市場拡大の妨げとなる可能性があります。とはいえ、需要の増加、技術革新、低侵襲的ソリューションへの嗜好の変化などが重なり、アテレクトミー装置プロバイダーは今後数年間、この成長市場で利益を上げることができると思われます。

目次

イントロダクション

  • 調査の目的
  • 定義
  • 市場範囲

調査手法

  • 情報調達
  • 二次・一次情報源
  • 市場規模の推定
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 市場概要見通し
  • 供給需要動向分析
  • セグメント別の機会分析

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • ポーターの分析

主な市場の考察

  • 主な成功要因
  • 競合の程度
  • 主な投資機会
  • イノベーションマトリクス
  • 技術分析
  • 規制分析
  • 特許分析
  • 市場のエコシステム

アテレクトミー装置市場:製品別

  • 市場概要
  • 方向性アテレクトミーシステム
  • 眼窩アテレクトミーシステム
  • 光アブレーション(レーザー)アテレクトミーシステム
  • 回転式アテレクトミーシステム
  • サポート装置
  • その他

アテレクトミー装置市場:用途別

  • 市場概要
  • 末梢血管
  • 心臓血管
  • 神経血管

アテレクトミー装置市場:エンドユーザー別

  • 市場概要
  • 病院と外科センター
  • 外来診療センター
  • 研究室および学術機関
  • その他

アテレクトミー装置市場:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ
  • 中東・アフリカ(MEA)
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2023年)

主要企業プロファイル

  • Medtronic Plc(Ireland)
  • Boston Scientific Corporation(USA)
  • Cardiovascular Systems, Inc.(USA)
  • Royal Philips(Netherlands)
  • Avinger, Inc.(USA)
  • Terumo Corporation(Japan)
  • AngioDynamics, Inc.(USA)
  • Braun Group(Germany)
  • Abbott Laboratories(USA)
  • B. Braun Melsungen AG(Germany)
  • Biotronik SE & Co. KG(Germany)
  • Biomerics(USA)
  • Philips(Netherlands)
  • Cook Medical, Inc.(USA)
  • Cardinal Health, Inc.(USA)
  • Rex Medical, L.P.(USA)
  • W. L. Gore & Associates, Inc.(USA)
  • Minnetronix, Inc.(USA)
  • Merit Medical Systems, Inc.(USA)
  • NexStep Medical(USA)
目次
Product Code: SQMIG35A2953

Global Atherectomy Devices Market size was valued at around USD 890.30 million in 2022 and is expected to rise from USD 962.41 million in 2023 to reach a value of USD 1794.60 million by 2031, at a CAGR of 8.1% over the forecast period (2024-2031).

The global market for atherectomy devices is poised for significant growth, driven largely by the escalating incidence of cardiovascular diseases, which are increasingly prevalent due to a growing elderly population, poor lifestyle choices, and unhealthy dietary habits. This rising health concern is expected to bolster the demand for atherectomy devices as more patients seek effective treatment options. Additionally, the trend towards minimally invasive procedures is gaining traction, presenting new avenues for providers of atherectomy devices as healthcare professionals and patients alike favor less invasive options for cardiovascular interventions. Furthermore, ongoing investments in medical research and development are anticipated to propel technological advancements in atherectomy devices, creating even more opportunities in this sector. However, the market faces challenges, including the high costs associated with atherectomy procedures and devices, potential risks of complications during operations, and the availability of alternative treatment options, which may hinder market expansion in the long term. Nonetheless, the confluence of increasing demand, technological innovations, and a shifting preference towards minimally invasive solutions positions atherectomy device providers to capitalize on this growing market in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Atherectomy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Atherectomy Devices Market Segmental Analysis

Global Atherectomy Devices Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Directional Atherectomy Devices, Orbital Atherectomy Devices, Photo-Ablative Atherectomy Devices, Rotational Atherectomy Devices, Support Devices, and Others. Based on Application, the market is segmented into Peripheral Vascular, Cardiovascular, and Neurovascular. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Care Centers, Research Laboratories & Academic Institutes, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Atherectomy Devices Market

The global atherectomy devices market is significantly driven by the aging population, which is increasingly at risk for cardiovascular complications like arterial blockages. As older individuals often experience a higher prevalence of such conditions, the demand for effective treatment options is rising. Atherectomy devices, essential for addressing these disorders, are gaining traction due to a growing preference for minimally invasive procedures among geriatric patients. This trend not only enhances patient outcomes but also aligns with the broader shift towards less invasive, safer medical interventions, thereby propelling the market's expansion and adoption in cardiovascular care strategies worldwide.

Restraints in the Global Atherectomy Devices Market

One of the significant market restraints for the global atherectomy devices market is the inherent risk of complications associated with atherectomy procedures. The complexity of these procedures, influenced by numerous variables such as patient anatomy, operator skill, and device selection, presents challenges in ensuring optimal outcomes. The fear of potential complications, including vessel perforation, dissection, or embolization, can deter both healthcare providers and patients from opting for atherectomy as a treatment option. Consequently, the apprehension surrounding these risks may hinder the growth of atherectomy device sales, as medical professionals may seek alternative treatment modalities perceived as less risky.

Market Trends of the Global Atherectomy Devices Market

The Global Atherectomy Devices market is witnessing a notable trend towards the integration of advanced technologies, particularly artificial intelligence (AI) and machine learning (ML). Manufacturers are increasingly focusing on these innovations to enhance the functionality and precision of their devices, ultimately improving patient outcomes in vascular interventions. By harnessing AI and ML, companies can streamline both the development processes and clinical deployment of atherectomy systems, thereby maximizing their operational efficiency and market reach. This technological shift is expected to drive competitive advantage in the marketplace, positioning manufacturers at the forefront of the evolving landscape of cardiovascular treatment solutions.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Innovation Matrix
  • Technology Analysis
  • Regulatory Analysis
  • Patent Analysis
  • Ecosystem of the Market

Global Atherectomy Devices Market, By Product

  • Market Overview
  • Directional Atherectomy Systems
  • Orbital Atherectomy Systems
  • Photo-Ablative (Laser) Atherectomy Systems
  • Rotational Atherectomy Systems
  • Support Devices
  • Others

Global Atherectomy Devices Market, By Application

  • Market Overview
  • Peripheral Vascular Applications
  • Cardiovascular Applications
  • Neurovascular Applications

Global Atherectomy Devices Market, By End User

  • Market Overview
  • Hospitals & Surgical Centers
  • Ambulatory Care Centers
  • Research Laboratories & Academic Institutes
  • Others

Atherectomy Devices Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Medtronic Plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardiovascular Systems, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Royal Philips (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Avinger, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AngioDynamics, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Braun Group (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotronik SE & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biomerics (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Philips (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rex Medical, L.P. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • W. L. Gore & Associates, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Minnetronix, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merit Medical Systems, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NexStep Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments